- Sentiments on Wall Street are mixed at the beginning of the session on Tuesday; US2000 gains 0.5%
- US durable goods, Conference Board Consumer Index and Richmond Fed stronger than expected
- EchoStar (SATS.US) surges almost 80% after the business deal with AT&T
- The US aerospace and defence company Heico (HEI.US) surges 8.5% after robust earnings report
- Nvidia (NVDA.US) will report earnings after the bell on Wall Street; shares gain almost 0.5% today and are close to the ATH;Ā the companyĀ hasĀ risen 34% year-to-date and was the top-performing Dow stock on Monday.Ā
According to the Conference Board: "The share of consumers expecting a recession over the next 12 months rose in August to the highest level since the April peak.Ā Consumers' average 12-month inflation expectations picked up after three consecutive months of easing and reached 6.2% in Augustāup from 5.7% in July but still below the April peak of 7%."
US100 (H1 interval)

Source: xStation5
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appCompany news
-
AT&T risesĀ after announcing plans to buy spectrum licenses from EchoStar for $23 billion. The deal gives AT&T exclusive rights to parts of the radio spectrum in key regions, supporting its long-term push to stay a leader in 5G and fiber connectivity. EchoStar shares skyrocketed almostĀ 80% on the news.
-
Interactive Brokers climbesĀ after S&P Dow Jones Indices said the online broker will join the S&P 500 on Thursday, replacing Walgreens Boots Alliance. Walgreens is being acquired by private-equity firm Sycamore Partners.
-
Talen Energy gained 4.3% after being tapped to replace Interactive Brokers in the S&P MidCap 400 index, also effective Thursday.
-
Advanced Micro Devices (AMD)Ā slightly gains after Truist analysts upgraded the stock to Buy from Hold and lifted their price target to $213 from $173. Analysts see AMD taking market share from Nvidia in the lucrative data-center GPU market.
-
Eli Lilly gains more thanĀ 2% after reporting that its experimental weight-loss pill orforglipron helped overweight and obese Type 2 diabetes patients lose up to 10.5% of body weight in a late-stage trial.
-
Palantir Technologies shares slipĀ after a 1% drop on Monday. CEO Alex Karp sold more than 400,000 shares last week, according to an SEC filing. The company sells AI-driven data analytics software.
-
Serina Therapeutics surged 31% after the FDA supported trials for its experimental Parkinsonās drug SER-252. The company plans to advance the drug under the FDAās new drug application pathway.
-
Semtech, a semiconductor maker, gained after reporting Q2 adjusted earnings of 41 cents per share, just above estimates. Revenue hit $258 million, up 20% year over year, and topped forecasts.
Heico shares surge after the earnings report
HeicoĀ jumps 8% after reporting Q3 earnings of $1.26 per share, beating analyst forecasts of $1.13. Revenue came in at $1.15 billion, also above expectations of $1.12 billion. Shares of the US defense and aerospace contractor surges almost 8% today.
-
Revenue: $1.15 billion, up 15.7% year-over-year (record sales).
-
EPS: $1.26, up 30% year-over-year (vs. $0.97 last year).
-
Flight Support Group (FSG):
-
Revenue $802.7 million, up 17.8% year-over-year.
-
Operating income $198.3 million.
-
-
Electronic Technologies Group (ETG):
-
Revenue $355.9 million, up 10.5% year-over-year.
-
Operating income $81 million.
-
-
Corporate & Intersegment:
-
Revenue ā$10.9 million, down 5% year-over-year.
-
Operating loss ā$14.3 million, an improvement from analystsā view.
-
-
Strong organic demand in both FSG and ETG segments; contribution from recent acquisitions.
-
Heico acquired Gables Engineering in July, expanding into advanced avionics controls.
Ā The companyĀ delivered record sales and earnings in Q3 2025, with both core business segments (FSG and ETG) posting solid double-digit growth.

Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the clientās needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any clientās actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.